Recro Pharma, Inc. (REPH) Reaches $8.09 Formed H&S; Gladstone Capital (GLAD) Has 1.24 Sentiment

Recro Pharma, Inc. (REPH) formed H&S with $7.77 target or 4.00% below today’s $8.09 share price. Recro Pharma, Inc. (REPH) has $154.74 million valuation. The stock increased 3.19% or $0.25 during the last trading session, reaching $8.09. About 109,040 shares traded. Recro Pharma, Inc. (NASDAQ:REPH) has risen 26.61% since February 13, 2017 and is uptrending. It has outperformed by 9.91% the S&P500.

The stock decreased 0.77% or $0.07 during the last trading session, reaching $8.98. About 164,398 shares traded. Gladstone Capital Corporation (GLAD) has risen 40.20% since February 13, 2017 and is uptrending. It has outperformed by 23.50% the S&P500.

Investors sentiment decreased to 1.65 in 2017 Q3. Its down 0.56, from 2.21 in 2017Q2. It turned negative, as 7 investors sold Recro Pharma, Inc. shares while 10 reduced holdings. 5 funds opened positions while 23 raised stakes. 9.63 million shares or 4.72% less from 10.10 million shares in 2017Q2 were reported. Goldman Sachs Grp, New York-based fund reported 56,658 shares. Nationwide Fund Advsrs holds 0% or 7,576 shares in its portfolio. The Ontario – Canada-based Royal Fincl Bank Of Canada has invested 0% in Recro Pharma, Inc. (NASDAQ:REPH). Alyeska Gru Ltd Partnership holds 0.07% or 906,398 shares. Jacobs Levy Equity Mngmt Incorporated owns 33,164 shares or 0.01% of their US portfolio. Renaissance Tech Limited Liability Co holds 0% in Recro Pharma, Inc. (NASDAQ:REPH) or 98,900 shares. The United Kingdom-based Barclays Public Limited Company has invested 0% in Recro Pharma, Inc. (NASDAQ:REPH). Parametric Portfolio Assoc Ltd owns 16,428 shares. Cadence Capital Management Limited Liability Corporation reported 167,637 shares. Legal General Gp Public Ltd Company has invested 0% in Recro Pharma, Inc. (NASDAQ:REPH). Jpmorgan Chase And holds 21,784 shares. State Common Retirement Fund has invested 0% of its portfolio in Recro Pharma, Inc. (NASDAQ:REPH). Northern Trust stated it has 0% in Recro Pharma, Inc. (NASDAQ:REPH). American Interest Grp reported 0% in Recro Pharma, Inc. (NASDAQ:REPH). Geode Limited Co accumulated 115,358 shares.

Since December 12, 2017, it had 0 buys, and 5 selling transactions for $1.43 million activity. SCP Vitalife Partners II LP also sold $344,688 worth of Recro Pharma, Inc. (NASDAQ:REPH) shares. Broadfin Healthcare Master Fund Ltd also sold $919,128 worth of Recro Pharma, Inc. (NASDAQ:REPH) shares. 1,579 Recro Pharma, Inc. (NASDAQ:REPH) shares with value of $13,956 were sold by SCP Vitalife Partners (Israel) II – L.P..

Among 8 analysts covering Recro Pharma (NASDAQ:REPH), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Recro Pharma had 14 analyst reports since August 25, 2015 according to SRatingsIntel. The stock of Recro Pharma, Inc. (NASDAQ:REPH) has “Overweight” rating given on Monday, December 19 by Piper Jaffray. The rating was upgraded by Zacks to “Hold” on Tuesday, August 25. Brean Capital initiated it with “Buy” rating and $21 target in Monday, October 3 report. The company was initiated on Monday, August 29 by Janney Capital. The stock has “Buy” rating by H.C. Wainwright on Tuesday, November 24. The rating was initiated by H.C. Wainwright with “Buy” on Wednesday, September 2. The stock of Recro Pharma, Inc. (NASDAQ:REPH) earned “Buy” rating by Aegis Capital on Monday, November 14. As per Thursday, November 9, the company rating was maintained by Roth Capital. The rating was initiated by Roth Capital on Friday, September 16 with “Buy”. Roth Capital maintained Recro Pharma, Inc. (NASDAQ:REPH) rating on Thursday, July 20. Roth Capital has “Buy” rating and $2000 target.

Analysts await Recro Pharma, Inc. (NASDAQ:REPH) to report earnings on March, 5. They expect $-0.78 EPS, up 3.70% or $0.03 from last year’s $-0.81 per share. After $-0.48 actual EPS reported by Recro Pharma, Inc. for the previous quarter, Wall Street now forecasts 62.50% negative EPS growth.

Bard Associates Inc holds 0.13% of its portfolio in Gladstone Capital Corporation for 29,350 shares. Koshinski Asset Management Inc. owns 25,821 shares or 0.08% of their US portfolio. Moreover, Cue Financial Group Inc. has 0.07% invested in the company for 10,300 shares. The United Kingdom-based Gsa Capital Partners Llp has invested 0.06% in the stock. Mckinley Capital Management Llc Delaware, a Unknown-based fund reported 126,140 shares.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: